Melphalan 140 mg/m(2) or 200 mg/m(2) for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party.

Auner HW, Iacobelli S, Sbianchi G, Knol-Bout C, Blaise D, Russell NH, Apperley JF, Pohlreich D, Browne PV, Kobbe G, Isaksson C, Lenhoff S, Scheid C, Touzeau C, Jantunen E, Anagnostopoulos A, Yakoub-Agha I, Tanase A, Schaap N, Wiktor-Jedrzejczak W, Krejci M, Schönland SO, Morris C, Garderet L, Kröger N

Open source

DOI: 10.3324/haematol.2017.181339
Published: 2018 Mar
Container: Haematologica
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2017.181339,
  title = {Melphalan 140 mg/m(2) or 200 mg/m(2) for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party.},
  author = {Auner HW and Iacobelli S and Sbianchi G and Knol-Bout C and Blaise D and Russell NH and Apperley JF and Pohlreich D and Browne PV and Kobbe G and Isaksson C and Lenhoff S and Scheid C and Touzeau C and Jantunen E and Anagnostopoulos A and Yakoub-Agha I and Tanase A and Schaap N and Wiktor-Jedrzejczak W and Krejci M and Schönland SO and Morris C and Garderet L and Kröger N},
  year = {2018},
  journal = {Haematologica},
  doi = {10.3324/haematol.2017.181339},
  url = {https://doi.org/10.3324/haematol.2017.181339}
}

RIS

TY  - JOUR
TI  - Melphalan 140 mg/m(2) or 200 mg/m(2) for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party.
AU  - Auner HW
AU  - Iacobelli S
AU  - Sbianchi G
AU  - Knol-Bout C
AU  - Blaise D
AU  - Russell NH
AU  - Apperley JF
AU  - Pohlreich D
AU  - Browne PV
AU  - Kobbe G
AU  - Isaksson C
AU  - Lenhoff S
AU  - Scheid C
AU  - Touzeau C
AU  - Jantunen E
AU  - Anagnostopoulos A
AU  - Yakoub-Agha I
AU  - Tanase A
AU  - Schaap N
AU  - Wiktor-Jedrzejczak W
AU  - Krejci M
AU  - Schönland SO
AU  - Morris C
AU  - Garderet L
AU  - Kröger N
PY  - 2018
JO  - Haematologica
DO  - 10.3324/haematol.2017.181339
UR  - https://doi.org/10.3324/haematol.2017.181339
ER  -

APA

HW, A., S, I., G, S., C, K., D, B., NH, R., JF, A., D, P., PV, B., G, K., C, I., S, L., C, S., C, T., E, J., A, A., I, Y., A, T., N, S., W, W., M, K., SO, S., C, M., L, G., & N, K. (2018). Melphalan 140 mg/m(2) or 200 mg/m(2) for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party.. Haematologica. https://doi.org/10.3324/haematol.2017.181339

Source records

pubmed · retrieved 2026-09-25T23:55:13.800Z
europe-pmc · retrieved 2026-09-25T23:55:13.811Z
doaj · retrieved 2026-09-25T23:55:13.818Z
hal · retrieved 2026-09-25T23:55:13.863Z